drugset / Trial / NCT02638415

Summary

The purpose of the study is to compare the effect of HVPG-guided individualized therapy and non-HVPG guided traditional therapy in cirrhotic patients for secondary prophylaxis.

Timeline

Start
2015-12
Primary completion
2018-06
Completion
2018-09

Drugs

EvaluationDrugModalityDoseRoute
Background Carvedilol Other / unclassified 12.5 mg